Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 54Neoplasms 38Lung Neoplasms 24Colorectal Neoplasms 24Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Pancreatic Neoplasms 9Hematologic Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Lymphoma 8Depression 8Ovarian Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Papillomavirus Infections 5Pain 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4

Interventions

Rituximab 416Cyclophosphamide 348Vincristine 173Prednisone 172Doxorubicin 168Etoposide 160Peripheral Blood Stem Cell Transplantation 114Filgrastim 108Lenalidomide 97fludarabine phosphate 96Radiotherapy 80Cytarabine 80Gemcitabine 73Melphalan 66Mycophenolic Acid 64Cyclosporine 60Methotrexate 59Busulfan 57Ifosfamide 55Carmustine 55fludarabine 50Tacrolimus 50Whole-Body Irradiation 49Carboplatin 49polatuzumab vedotin 44Oxaliplatin 44Dexamethasone 44Antilymphocyte Serum 42ibrutinib 40Bendamustine Hydrochloride 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Methods × Clear all
NCT00324831 2013-12-18

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

National Cancer Institute (NCI)

Phase 3 Suspended
480 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡